CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer.

Liang, Yuan-Ke; Deng, Ze-Kun-; Chen, Mu-Tong; Qiu, Si-Qi; Xiao, Ying-Sheng; Qi, Yu-Zhu; Xie, Qin; Wang, Zheng-Hao; Jia, Shi-Cheng; Zeng, De; Lin, Hao-Yu

Liang, Yuan-Ke; Deng, Ze-Kun-; Chen, Mu-Tong; Qiu, Si-Qi; Xiao, Ying-Sheng; Qi, Yu-Zhu; Xie, Qin; Wang, Zheng-Hao; Jia, Shi-Cheng; Zeng, De; Lin, Hao-Yu.

Affiliation

Liang YK; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College (SUMC), Shantou, China.
Deng ZK; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou, China.
Chen MT; Department of Thyroid and Breast Surgery, Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College (SUMC), Shantou, China.
Qiu SQ; SUMC, Shantou, China.
Xiao YS; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou, China.
Qi YZ; Clinical Research Center, Diagnosis and Treatment Center of Breast Diseases, Shantou Central Hospital, Shantou, China.
Xie Q; Guangdong Provincial Key Laboratory for Diagnosis and Treatment of Breast Cancer, Shantou, China.
Wang ZH; Department of Thyroid Surgery Shantou Central Hospital, Shantou, China.
Jia SC; SUMC, Shantou, China.
Zeng; Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Lin HY; SUMC, Shantou, China.

Front Oncol ; 11: 710286, 2021.

Article in En | MEDLINE | ID: mdl-34527583

Key words

CXCL9; biomarker; breast cancer; immune infiltration; prognosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2021 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google